Acorda to Buy Civitas Therapeutics, Developer of Parkinson

Share

(September 29, 2014) - Acorda Therapeutics Inc. plans to buy privately-held Civitas Therapeutics as the drugmaker seeks to expand into treatments for Parkinson's disease. Civitas, is currently testing an inhaler treatment, called CVT-301, which reduces tremors and reduced movement caused by Parkinson's disease. Read more…

Click for a printer friendly version

Back to top